Novotalk

Digital Therapy for People with Speech Disorders

Health Tech & Life Sciences
Active
Mature Bnei Brak, Israel Founded 2014
Last updated 2026-06-18
Total raised
Last: 2018-10
Stage
Mature
Founded
2014
Headcount
7
HQ
Bnei Brak, Israel
Sector
Health Tech & Life Sciences

About

Novotalk develops on-demand (asynchronous), self-directed speech and language teletherapy solutions that allow individuals with speech impairments to learn, practice, gain, and maintain intelligible speech remotely, independently, and discreetly. The companys first commercialized product is a patented web and mobile application that provides self-directed speech therapy and training to people who stutter, enabling regular Novotalk users to experience fluent speech. The first version is in Hebrew and English. Novotalk has signed a joint venture agreement with Mount Sinai Health System in New York for commercialization in North America and future research and development collaborations. Novotalk is available to patients in Israel in collaboration with Hadassah Medical Center in Jerusalem.

Funding history · 3 rounds · — total

2018-10
Undisclosed
2017-05
Grant Undisclosed
Date unknown
Undisclosed

Q&A

What is Novotalk's primary focus?
Novotalk specializes in developing on-demand, self-directed speech and language teletherapy solutions for individuals with speech impairments.
What is Novotalk's first commercialized product?
Novotalk's first commercialized product is a patented web and mobile application designed to provide self-directed speech therapy and training for people who stutter, available in Hebrew and English.
When was Novotalk founded?
Novotalk was founded in March 2014.
Which organizations has Novotalk partnered with for commercialization and research?
Novotalk has a joint venture agreement with Mount Sinai Health System in New York for North American commercialization and future R&D. They also collaborate with Hadassah Medical Center in Jerusalem to make their services available to patients in Israel.
What type of funding did Novotalk receive in May 2017?
In May 2017, Novotalk received a Grant from MassChallenge Israel.
Which investor participated in Novotalk's funding round in October 2018?
Mount Sinai Ventures participated in Novotalk's funding round in October 2018.
What is Novotalk's primary sector?
Novotalk's primary sector is Health Tech & Life Sciences.

Team · 1

Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligencePlatforms & InterfacesWeb
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsEducationK12 EducationFinancial ServicesFinancial ProductsInsurance
Business model
B2CB2B2C

Highlights

1 PatentsVerified

Tags

artificial-intelligencenon-invasivedata-analyticsclinicstherapeuticsschoolsinsurance-companiestelemedicinepatientsweb-platformmobile-applicationshealthcare-providersmhealthspeech-analyticshospitalsdigital-healthcaredigital-therapeutics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)